Haemonetics (HAE) Gross Profit Growth (1y) (2010 - 2026)

Haemonetics (HAE) Gross Profit Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 6.52%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 1.76%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 4.41%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 12.59%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 15.74%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.30%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 27.39%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -1.74%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 8.72%
10 Haemonetics 3.50 Bn 3.25 Bn 198.21 Mn 2.67%

Historic Data

Download Data
DateValue
Mar 28, 2026 2.67%
Dec 27, 2025 4.57%
Sep 27, 2025 3.90%
Jun 28, 2025 9.90%
Mar 29, 2025 9.75%
Dec 28, 2024 8.82%
Sep 28, 2024 9.93%
Jun 29, 2024 4.58%
Mar 30, 2024 12.58%
Dec 30, 2023 12.07%
Sep 30, 2023 8.00%
Jul 1, 2023 17.57%
Apr 1, 2023 14.63%
Dec 31, 2022 14.54%
Oct 1, 2022 28.84%
Jul 2, 2022 31.62%
Apr 2, 2022 66.63%
Jan 1, 2022 15.22%
Oct 2, 2021 15.88%
Jul 3, 2021 20.05%